SPEECH BY MDM RAHAYU MAHZAM, MINISTER OF STATE, MINISTRY OF DIGITAL DEVELOPMENT AND INFORMATION & MINISTRY OF HEALTH, AT THE GLOBAL INNOVATION CONFERENCE FOR RESEARCH, POLICY, AND PRACTICE, 17 NOVEMBER 2026
17 November 2026
Distinguished guests
Researchers, practitioners, policymakers, philanthropic leaders, and partners from across the world
A very warm welcome to Singapore.
1. Good morning. What a wonderful idea to have us all see a drum performance at the start of the day to get us all energised and so excited. Thank you to Pew and the Centre for Evidence and Implementation (CEI) for all the efforts they have put in this conference. And I am honoured to join you today at the Global Innovation Conference for Research, Policy, and Practice.
Introduction: The Challenge of the Policy-Implementation Gap
2. Around the world, governments and societies are navigating rapid demographic shifts, climate risks, and advances in science and technology, particularly, artificial intelligence (AI). How we respond will shape whether these changes improve lives broadly or deepen existing divisions and inequalities.
3. A critical factor will be whether innovation can be translated into sound, evidence-informed policies. Ground-breaking research and cutting-edge technology are important, but they are only the starting point.
4. The greater challenge is translating them into policy, then practice, leading to better outcomes for all.
5. This is the implementation gap: where even promising solutions may fail because they do not sufficiently reflect the realities of delivery, the needs of communities, or the factors that influence acceptance and adoption.
6. Robyn mentioned earlier that I am with the Ministry of Digital Development and Information (MDDI), but I also wear another hat. In Singapore, typically you have a few portfolios. My other hat is with the Ministry of Health (MOH), and that is where I want to share some perspectives.
7. Today, I would like to share three ways Singapore is working to narrow the implementation gap described earlier, in the healthcare sector:
a) First, by advancing appropriate and value-based healthcare,
b) Second, enabling responsible innovation, and
c) Third, ensuring that the benefits of digitalisation are broadly shared.
Nationwide Push for Appropriate and Value-Based Care
8. Like many other countries, Singapore faces rising healthcare expenditure, driven in part by our ageing population, higher healthcare utilisation, and advances in medical technologies.
9. If this trajectory is left unchecked, costs could become an unsustainable burden. Our task therefore is to achieve better outcomes and value from every healthcare dollar.
10. This is the purpose of our nationwide push for Appropriate and Value-Based Care (AVBC): to deliver evidence-based practices while avoiding the overuse, underuse, or misuse of healthcare interventions, keeping our healthcare system sustainable.
11. To guide this effort, we use a simple framework: FOCUS. Each letter points to one part of our approach – Financing, Outcomes, Cost-effective interventions, avoiding Unwarranted variation and waste reduction, and Skills enhancement.
12. Let me take each in turn.
a) F is for Financing: We prioritise payments and subsidies for interventions that are evidence-based and deliver good value.
b) O is for Outcomes: We measure not only clinical measures, such as recovery rates, but also what matters to patients, including quality of life.
c) C is for Cost-effective interventions: We identify, pilot and scale approaches that work, nationally through the Agency for Care Effectiveness (ACE), and within our healthcare clusters and hospitals.
d) U is for reducing Unwarranted clinical variation and waste, so that scarce resources, including manpower, are directed towards proven innovations.
e) And S is for Skills enhancement: Equipping our healthcare workforce through education and training in data analytics, multidisciplinary collaboration and the principles of AVBC.
13. Taken together, these five elements help us keep the system focused on better outcomes, value, and care for patients.
14. One practical example is ACE’s work on Evidence to Practice (ETP), where important and relevant clinical topics are developed into what we call ACE Clinical Guidelines (or ACGs for short). We prioritise based on impact on health and cost, potential for clinical- and cost-effectiveness, national health priorities, as well as regulatory and policy considerations.
15. Recently, ACE published guidelines on pneumonia, skin infections, and dementia management, among others, which help clinicians make evidence-based decisions for better outcomes. ACGs are regularly updated and can be accessed conveniently at ACE’s website.
16. Precision medicine offers another example of how research is translated into clinical care. Findings from Phase II of Singapore’s National Precision Medicine (NPM) Programme helped inform the implementation of genomics in mainstream clinical care, including the implementation of the National Familial Hypercholesterolaemia (FH) Genetic Testing Programme.
17. As FH is an inherited genetic condition which greatly increases the risk of heart disease, the programme aims to identify individuals with FH early to enable timely intervention and facilitate further screening of family members.
18. Building on the progress from Phase II, Phase III of the NPM programme aims to scale up Singapore’s precision medicine efforts by sequencing the whole genomes of 450,000 people, roughly 10% of Singapore’s resident population, to build a world-class genomic database that reflects Asia’s diversity.
19. These examples illustrate the opportunity created when research, policy, and delivery are connected. But as innovation becomes more data-intensive, it also raises important questions around data protection, responsible use, proper governance, and public trust.
Bridging Innovation and Governance
20. Through my work across MDDI and MOH, I often speak about the necessity of bridging two worlds: technical innovation and domain practice.
21. In healthcare, an AI model may perform impressively in a lab, but may have limited value if it does not address a genuine clinical need or fit into the workflow of a busy hospital. That is why our clinicians work directly with AI developers, and are often developers themselves, crafting relevant tools like notetaking buddies to save documentation time, or apps which assist with identifying clinical issues earlier.
22. PENSIEVE-AI is a digital drawing app co-developed by the Singapore General Hospital (SGH) and GovTech that simplifies laborious examinations into four simpler drawing tasks, which seniors can do themselves on a touch-screen tablet using a stylus pen. The app’s AI analyses drawings for early signs of cognitive decline in seniors to enable early interventions, with 93% accuracy in detecting early cognitive impairment.
23. Starting from early 2027, SGH will roll out PENSIEVE-AI in community sites for further testing, ensuring this innovation integrates seamlessly into frontline healthcare workflows.
24. When considering treatment, AI can augment doctors’ decision-making. In the field of surgery, patients often require antibiotics, and doctors decide based on numerous factors, like the type of surgery or the patient’s medical conditions and allergies.
25. Proph Abby, an AI assistant powered by government chatbot Pair, combs through existing evidence-based surgical antibiotic guidelines and gives doctors recommendations within five minutes. This reduces time and errors, even for complex cases where more references and calculations are required. Importantly, the clinician remains the decision-maker, assisted by recommendations from the AI assistant.
26. Scaling such innovations requires a strong foundation of governance and trust. MOH and the Health Sciences Authority (HSA) recently refreshed our AI in Healthcare Guidelines (AIHGle 2.0), to guide the safe, ethical, and effective use of AI in clinical settings.
27. The updated guidelines emphasise the importance of clinical oversight, and clarify the responsibilities of developers, healthcare organisations, and healthcare professionals throughout the AI lifecycle. This enables responsible innovation while protecting patient safety and maintaining public trust.
28. Responsible innovation is not only about whether technology is safe and effective. It is also about who can access it, use it confidently, and benefit from it.
Digital Inclusion and the Community Spirit
29. This brings me to the core theme of this conference: Ensuring research, policy, and practice work together to build a truly inclusive society.
30. As digital tools and AI become central to accessing healthcare, government services, and economic opportunities in daily life, we must ask ourselves a fundamental question: How do we ensure no one is left behind?
31. In Singapore, our approach to digital inclusion rests on a whole-of-society partnership. Government cannot resolve all the problems and all the complex challenges alone. Collaboration allows us to reach further than any single actor can.
32. Many seniors face barriers in adopting digital tools, whether due to unfamiliarity, usability challenges, or concerns about trust. This is why digital health solutions should be co-designed with users, supported by ongoing guidance, and anchored in trusted community relationships.
33. One example is our Health Promotion Board’s (HPB) Age Strong digital health programme, which supports adults aged 50 and above in building habits that help them stay active, independent and engaged. Through the Healthy 365 app, participants can participate in guided exercises and obtain practical health information anytime, at their own pace.
34. Age Strong is designed to meet people where they are, with activities tailored to different abilities and needs. By combining digital tools, behavioural science and regular user feedback, HPB continues to refine the programme so that the technology becomes an enabler, rather than a barrier, of healthier ageing.
35. Support is also available for less digitally savvy seniors seeking to equip themselves with digital skills for daily living. Seniors can approach Digital Ambassadors from the Infocomm Media Development Authority’s (IMDA) SG Digital Office (SDO) at selected community hubs, public libraries and healthcare institutions across Singapore, to equip them with the skills to embrace health related digital services such as making medical appointments and ordering medications. Over time, Digital Ambassadors have become trusted touchpoints for learning digital skills.
Conclusion: A Call to Action for the Global Community
36. Ultimately, research and digital tools alone do not change lives. What makes the difference is how they are translated into policy, embedded into sustainable practice, and adopted by people.
37. This conference reminds us that the purpose of generating evidence is not just to produce sophisticated technologies, but to deliver measurable, real-world impact. Evidence must inform decisions. Innovation must serve people. And policy must close the gap between what is possible and what is meaningful.
38. Today, we have advanced technologies and data at our disposal. Our responsibility is to ensure that they remain firmly anchored to the ends we seek: Better health, greater equity, stronger trust, and improved lives for those we serve.
39. As you participate in the various conference sessions over the next few days, I invite you to reflect on these few questions:
a) How will this work for the frontliner, the caregiver, or the resident in their context?
b) Who can I partner to make this work?
c) How can my work build trust and improve quality of life for all?
40. In Singapore, we strive to be a place where ideas can be tested, refined, and shared with the global community. But no country has all the answers.
41. The challenges we face – from ageing populations and rising healthcare costs to technological disruption – are shared challenges. Addressing them will require partnership, learning, and collective resolve, which I believe you will find here in this room.
42. Thank you very much, and I wish you all a fruitful and impactful conference.
